Form 4: Envista Holdings Director Barbara Hulit Receives Annual Equity Grant

Sentiment:

Insider Transaction Report


Envista Holdings Corp. Director Barbara B. Hulit was granted 10,450 Restricted Stock Units as part of her annual equity compensation, vesting on the first anniversary of the grant date.

Summary

  • Barbara B. Hulit, a Director of Envista Holdings Corp. (NVST), acquired 10,450 shares of common stock.
  • This acquisition was an annual equity grant of Restricted Stock Units (RSUs) for her service as a director.
  • The RSUs will vest on the first anniversary of the grant date, converting into common stock shares on a one-to-one basis.
  • Following this transaction, Ms. Hulit beneficially owns a total of 79,820 shares of common stock.

Sentiment

Score: 7

Explanation: Neutral to slightly positive. This is a routine and expected compensation event for a director, which aligns their interests with shareholders. It does not signal any negative operational or financial issues for the company.

Positives

  • The grant of Restricted Stock Units (RSUs) aligns the director's interests with long-term shareholder value, as the units vest over time and are tied to the company's stock performance.
  • This transaction represents standard compensation for director services, indicating ongoing commitment from board members to the company's governance and strategic direction.

Future Outlook

The granted Restricted Stock Units are scheduled to vest on the first anniversary of the grant date, which will result in the conversion of these units into common stock shares.

Industry Context

This transaction is a routine insider filing, reflecting standard corporate governance practices where public companies, including those in the healthcare and dental equipment industry like Envista Holdings, compensate non-employee directors with equity to align their interests with shareholders.

Comparison to Industry Standards

  • Equity compensation, particularly through Restricted Stock Units (RSUs), is a common and widely accepted practice for compensating non-employee directors across publicly traded companies, including those within the medical and dental device sector.
  • The specific size of the RSU grant (10,450 units) would typically be benchmarked against director compensation packages at peer companies of similar market capitalization and industry to assess its competitiveness, though such comparative data is not provided within this filing.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director CompensationAnnual equity grant of 10,450 Restricted Stock Units (RSUs) to Director Barbara B. Hulit for her service.06/10/2025This grant aligns the director's long-term interests with those of the shareholders and is a standard component of director compensation, reinforcing commitment to corporate governance.

Stakeholder Impact

  • Shareholders: The grant of RSUs to a director aligns their financial interests with those of the shareholders, as the value of the compensation is directly tied to the company's stock performance over time.

Next Steps

  • The 10,450 Restricted Stock Units granted to Barbara B. Hulit are expected to vest on the first anniversary of the grant date (approximately June 10, 2026), at which point they will convert into common stock shares.

Key Dates

DateDescription
06/10/2025Date of transaction (grant of Restricted Stock Units)
06/12/2025Signature date of the SEC Form 4 filing
06/10/2026Approximate vesting date for the granted RSUs (first anniversary of grant date)

Recommendation

hold

Keywords

Envista Holdings Corp, NVST, Form 4, Restricted Stock Units, RSUs, Equity Grant, Director Compensation, Insider Transaction, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.